Hernández-Quero J - Search Results

1

Patients' characteristics and clinical implications of suboptimal CD4 T-cell gains after 1 year of successful antiretroviral therapy.

Gutiérrez F, Padilla S, Masiá M, Iribarren JA, Moreno S, Viciana P, Hernández-Quero J, Alemán R, Vidal F, Salavert M, Blanco JR, Leal M, Dronda F, Perez Hoyos S, del Amo J; CoRIS-MD. Gutiérrez F, et al. Curr HIV Res. 2008 Mar;6(2):100-7. doi: 10.2174/157016208783885038. Curr HIV Res. 2008. PMID: 18336257

2

[Immunological, virological and clinical response in patients infected with HIV after highly active antiviral therapy with nelfinavir: prospective cohort study].

de Alarcón A, Viciana P, Lozano F, Vergara A, Pujol E, Barrera A, Pérez-Guzmán E, Colmenero MA, Hernández-Quero J, Márquez M, de la Torre J, Aliaga L, Suárez I, Gutiérrez-Ravé V, Torres-Tortosa M, Marín J, Valdayo MJ, Milla M; Grupo Andaluz para el Estudio de las Enfermedades Infecciosas. de Alarcón A, et al. Enferm Infecc Microbiol Clin. 2003 Dec;21(10):543-51. Enferm Infecc Microbiol Clin. 2003. PMID: 14642252 Clinical Trial. Spanish.

3

A cohort study of the food effect on virological failure and treatment discontinuation in patients on HAART containing didanosine enteric-coated capsules (FOODDIe Study).

López JC, Moreno S, Jiménez-Oñate F, Clotet B, Rubio R, Hernández-Quero J. López JC, et al. HIV Clin Trials. 2006 Jul-Aug;7(4):155-62. doi: 10.1310/hct0704-155. HIV Clin Trials. 2006. PMID: 17065027

4

Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C.

Macías J, Mira JA, López-Cortés LF, Santos I, Girón-González JA, González-Serrano M, Merino D, Hernández-Quero J, Rivero A, Merchante N, Trastoy M, Carrillo-Gómez R, Arizcorreta-Yarza A, Gómez-Mateos J, Pineda JA. Macías J, et al. Antivir Ther. 2006;11(7):839-46. Antivir Ther. 2006. PMID: 17302246

5

Pharmacokinetics of fosamprenavir plus ritonavir in human immunodeficiency virus type 1-infected adult subjects with hepatic impairment.

Pérez-Elías MJ, Morellon ML, Ortega E, Hernández-Quero J, Rodríguez-Torres M, Clotet B, Felizarta F, Gutiérrez F, Pineda JA, Nichols G, Lou Y, Wire MB. Pérez-Elías MJ, et al. Antimicrob Agents Chemother. 2009 Dec;53(12):5185-96. doi: 10.1128/AAC.00632-09. Epub 2009 Aug 10. Antimicrob Agents Chemother. 2009. PMID: 19667283 Free PMC article. Clinical Trial.

6

Genotypic determination of HIV tropism - clinical and methodological recommendations to guide the therapeutic use of CCR5 antagonists.

Poveda E, Alcamí J, Paredes R, Córdoba J, Gutiérrez F, Llibre JM, Delgado R, Pulido F, Iribarren JA, García Deltoro M, Hernández Quero J, Moreno S, García F. Poveda E, et al. AIDS Rev. 2010 Jul-Sep;12(3):135-48. AIDS Rev. 2010. PMID: 20842202 Review.

7

Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients.

Labarga P, Soriano V, Caruz A, Poveda E, Di Lello FA, Hernandez-Quero J, Moreno S, Bernal E, Miró JM, Leal M, Gutierrez F, Portilla J, Pineda JA; CoRIS. Labarga P, et al. AIDS. 2011 Mar 27;25(6):761-6. doi: 10.1097/QAD.0b013e32834488e7. AIDS. 2011. PMID: 21378537

8

Most HIV type 1 non-B infections in the Spanish cohort of antiretroviral treatment-naïve HIV-infected patients (CoRIS) are due to recombinant viruses.

Yebra G, de Mulder M, Martín L, Rodríguez C, Labarga P, Viciana I, Berenguer J, Alemán MR, Pineda JA, García F, Holguín A; Cohort of the Spanish AIDS Research Network (CoRIS). Yebra G, et al. J Clin Microbiol. 2012 Feb;50(2):407-13. doi: 10.1128/JCM.05798-11. Epub 2011 Dec 7. J Clin Microbiol. 2012. PMID: 22162552 Free PMC article.

9

Incidence and risk factors of AIDS-defining cancers in a cohort of HIV-positive adults: Importance of the definition of incident cases.

Suárez-García I, Jarrín I, Iribarren JA, López-Cortés LF, Lacruz-Rodrigo J, Masiá M, Gómez-Sirvent JL, Hernández-Quero J, Vidal F, Alejos-Ferreras B, Moreno S, Del Amo J. Suárez-García I, et al. Enferm Infecc Microbiol Clin. 2013 May;31(5):304-12. doi: 10.1016/j.eimc.2012.03.009. Epub 2012 May 18. Enferm Infecc Microbiol Clin. 2013. PMID: 22608566

10

Update on clinical and methodological recommendations for genotypic determination of HIV tropism to guide the usage of CCR5 antagonists.

Poveda E, Paredes R, Moreno S, Alcamí J, Córdoba J, Delgado R, Gutiérrez F, Llibre JM, García Deltoro M, Hernández-Quero J, Pulido F, Iribarren JA, García F. Poveda E, et al. AIDS Rev. 2012 Jul-Sep;14(3):208-17. AIDS Rev. 2012. PMID: 22833064 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

164 results

Search Page